Qube Research & Technologies LTD Olema Pharmaceuticals, Inc. Transaction History

Qube Research & Technologies LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.72 - $5.88 $11,342 - $24,519	-4,170 Reduced 16.47%	21,145 $58,000
Q2 2022 Aug 15, 2022	BUY	$2.04 - $4.61 $51,642 - $116,702	25,315 New	25,315 $103,000
Q1 2021 May 14, 2021	SELL	$27.81 - $53.64 $247,008 - $476,430	-8,882 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$37.09 - $54.5 $329,433 - $484,069	8,882 New	8,882 $427,000

145

58.3M

141K

23.1K

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $248M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.